These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9188011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
    Kawasuji M, Ueyama K, Sakakibara N, Tedoriya T, Matsunaga Y, Misaki T, Watanabe Y.
    Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
    [Abstract] [Full Text] [Related]

  • 3. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T, Gando S, Morimoto Y, Mashio H, Goda Y, Kawahigashi H, Kemmotsu O.
    Thromb Res; 2001 Dec 01; 104(5):301-7. PubMed ID: 11738071
    [Abstract] [Full Text] [Related]

  • 4. Strategies to reduce hemostatic activation during cardiopulmonary bypass.
    Eisses MJ, Velan T, Aldea GS, Chandler WL.
    Thromb Res; 2006 Dec 01; 117(6):689-703. PubMed ID: 15996721
    [Abstract] [Full Text] [Related]

  • 5. Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
    Eisses MJ, Seidel K, Aldea GS, Chandler WL.
    Anesth Analg; 2004 May 01; 98(5):1208-16, table of contents. PubMed ID: 15105189
    [Abstract] [Full Text] [Related]

  • 6. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A, Sasaki Y, Hirai H, Fukui T, Matsuo M, Takahashi Y, Kotani S, Suehiro S.
    Interact Cardiovasc Thorac Surg; 2010 Apr 01; 10(4):555-60. PubMed ID: 20061337
    [Abstract] [Full Text] [Related]

  • 7. Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements.
    Wiefferink A, Weerwind PW, van Heerde W, Teerenstra S, Noyez L, de Pauw BE, Brouwer RM.
    J Extra Corpor Technol; 2007 Jun 01; 39(2):66-70. PubMed ID: 17672185
    [Abstract] [Full Text] [Related]

  • 8. Plasmin generation and D-dimer formation during cardiopulmonary bypass.
    Chandler WL, Velan T.
    Blood Coagul Fibrinolysis; 2004 Oct 01; 15(7):583-91. PubMed ID: 15389126
    [Abstract] [Full Text] [Related]

  • 9. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
    Shibata T, Ishii T, Tomo T, Kaneko K, Nasu M, Magari Y, Fukushima K.
    Nihon Jinzo Gakkai Shi; 1991 Apr 01; 33(4):373-8. PubMed ID: 1831516
    [Abstract] [Full Text] [Related]

  • 10. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
    Eisses MJ, Chandler WL.
    J Cardiothorac Vasc Anesth; 2008 Feb 01; 22(1):53-9. PubMed ID: 18249331
    [Abstract] [Full Text] [Related]

  • 11. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets.
    Orchard MA, Goodchild CS, Prentice CR, Davies JA, Benoit SE, Creighton-Kemsford LJ, Gaffney PJ, Michelson AD.
    Br J Haematol; 1993 Nov 01; 85(3):533-41. PubMed ID: 7510990
    [Abstract] [Full Text] [Related]

  • 12. Laboratory modalities for assessing hemostasis during cardiopulmonary bypass.
    Fekete LF, Bick RL.
    Semin Thromb Hemost; 1976 Oct 01; 3(2):83-9. PubMed ID: 138934
    [Abstract] [Full Text] [Related]

  • 13. D-Dimer formation during cardiac and noncardiac thoracic surgery.
    Whitten CW, Greilich PE, Ivy R, Burkhardt D, Allison PM.
    Anesth Analg; 1999 Jun 01; 88(6):1226-31. PubMed ID: 10357323
    [Abstract] [Full Text] [Related]

  • 14. An alternative pathway for fibrinolysis is activated in patients who have undergone cardiopulmonary bypass surgery and major abdominal surgery.
    Gando S, Kameue T, Sawamura A, Hayakawa M, Hoshino H, Kubota N.
    Thromb Res; 2007 Jun 01; 120(1):87-93. PubMed ID: 17023030
    [Abstract] [Full Text] [Related]

  • 15. Activation of coagulation and fibrinolysis during cardiothoracic operations.
    Hunt BJ, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M.
    Ann Thorac Surg; 1998 Mar 01; 65(3):712-8. PubMed ID: 9527200
    [Abstract] [Full Text] [Related]

  • 16. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T, Muramatsu Y, Akashi S, Usui N.
    Nihon Jinzo Gakkai Shi; 1997 Mar 01; 39(2):144-9. PubMed ID: 9134831
    [Abstract] [Full Text] [Related]

  • 17. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H, Du Buit C, Soria J, Touchot B, Chollet B, Commin PL, Conseiller C, Echter E, Soria C.
    Thromb Haemost; 1994 Sep 01; 72(3):438-43. PubMed ID: 7531877
    [Abstract] [Full Text] [Related]

  • 18. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
    Slaughter TF, Faghih F, Greenberg CS, Leslie JB, Sladen RN.
    Anesth Analg; 1997 Dec 01; 85(6):1221-6. PubMed ID: 9390584
    [Abstract] [Full Text] [Related]

  • 19. Significance of D-dimer concentrations during and after cardiopulmonary bypass.
    Comunale ME, Carr JM, Moorman RM, Robertson LK.
    J Cardiothorac Vasc Anesth; 1996 Jun 01; 10(4):477-81. PubMed ID: 8776641
    [Abstract] [Full Text] [Related]

  • 20. Cardiopulmonary bypass. Associated hemostatic abnormalities.
    Kalter RD, Saul CM, Wetstein L, Soriano C, Reiss RF.
    J Thorac Cardiovasc Surg; 1979 Mar 01; 77(3):427-35. PubMed ID: 762986
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.